AI assistant
Vimian Group AB Capital/Financing Update 2025
8618_rns_2025-05-09_facf1c42-baf7-4d65-957d-a312e874760a.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Vimian contemplates issuance of a senior unsecured bond
Vimian Group AB (public) ("Vimian") has today mandated DNB Markets, a part of DNB Bank ASA, Sweden Branch, Nordea Bank Abp and Skandinaviska Enskilda Banken AB (publ) as joint bookrunners to arrange a series of fixed income investor meetings starting on 9 May 2024 to explore the possibility of issuing a senior unsecured bond denominated in EUR with floatingrate interest and expected maturity in 3 years. A capital markets transaction with an expected volume of EUR 125 million within a framework of EUR 250 million may follow, subject to prevailing market conditions.
The net proceeds from the bond issue will be used to refinance certain existing debt and for general corporate purposes, including acquisitions and investments.
The arrangers' target market is non-professional clients, professional clients, and eligible counterparties (all distribution channels).
For further information, please contact:
Carl-Johan Zetterberg Boudrie CFO [email protected] +46 70 335 84 49
About Vimian
Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market's most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.